Silexion Therapeutics secures ~$3.3M via warrant exercise inducement, issues new warrants

Silexion Therapeutics Corp

Holders exercise 2,221,523 existing warrants at $1.35 per share; new warrants issued for same number at $1.50.
Gross proceeds ~$3.3M; closing expected Jan 30, 2025; net proceeds for general corporate purposes.
Placement agent H.C. Wainwright receives 7.0% cash fee and 1.0% management fee; also receives placement agent warrants.
New warrants exercisable for 24 months from registration statement effective date; cashless exercise feature.
Company agrees not to issue shares or file registration statements until March 18, 2025; no Variable Rate Transactions for one year.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.